Results 131 to 140 of about 10,434 (181)
Some of the next articles are maybe not open access.
CONTRACEPTIVE AND ENDOMETRIAL EFFECTS OF MEDROXYPROGESTERONE ACETATE
Obstetrical & Gynecological Survey, 1969Present means of contraception are not satisfactory for all women. This study reports on the contraception efficacy and menstrual abnormalities of medroxyprogesterone acetate (Depo-Provera), which was given in an intramuscular dose of 150 mg. every 3 months for 1 year.
openaire +2 more sources
Medroxyprogesterone Acetate and Diabetes Mellitus
Annals of Internal Medicine, 1976Excerpt To the editor: Sutton and associates (1) observed one patient with a family history of diabetes mellitus who developed irreversible insulin-dependent diabetes after 1 year of, therapy with ...
JOSEPH C. BOTTINO, CHARLES K. TASHIMA
openaire +1 more source
Medroxyprogesterone Acetate in Cancer Cachexia
2007For a long time the use of testosterone-derivative drugs (nandrolone decanoate and others) has been indicated for patients with cancer anorexiacachexia syndrome (CACS) on the basis of a truly protein anabolic effect [1], but the above drugs have a limited use because of some severe sideeffects (liver damage, endocrine effects).
Giorgio Lelli +3 more
openaire +1 more source
Injectable Contraception with Depot Medroxyprogesterone Acetate
Drugs, 1993Depot medroxyprogesterone acetate (DMPA) the only injectable contraception approved in the United States in 1992 is used by 8-9 million women in more than 90 countries. DMPA inhibits ovulation by the reduction of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) plasma levels.
Andrew M, Kaunitz, Allan, Rosenfield
openaire +2 more sources
A potential mechanism in medroxyprogesterone acetate teratogenesis
Teratology, 1979AbstractMedroxyprogesterone acetate (MPA) has been shown to be teratogenic in rabbits but not in rats or mice (Andrew and Staples, 1977). Since normal steroid action appears to be mediated, in large part, through interaction with specific steroid receptors, we postulated that the species difference in teratogenicity might be due to a difference in the ...
G L, Kimmel, B S, Hartwell, F D, Andrew
openaire +2 more sources
Depot Medroxyprogesterone Acetate and Adolescents
Clinical Journal for Nurse Practitioners in Women's HealthDepot medroxyprogesterone acetate (DMPA) is an effective method of contraception that may be underutilized due to lack of information or access. This article updates clinicians on current evidence about the safety and potential side effects of DMPA.
Eva Fried, Mandi Lew, Maria Mock
openaire +1 more source
Integrative oncology: Addressing the global challenges of cancer prevention and treatment
Ca-A Cancer Journal for Clinicians, 2022Jun J Mao,, Msce +2 more
exaly